| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.79B | -37.3% |
| Cost of Revenue | $3.64B | -43.3% |
| Gross Profit | $2.15B | -23.4% |
| R&D Expense | $459.7M | -30.1% |
| SG&A Expense | $873.3M | -23.1% |
| Operating Income | -$112.9M | +84.2% |
| Interest Expense | $675.8M | +14.8% |
| Pre-tax Income | -$717.9M | +44.8% |
| Income Tax | $133.4M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $543.8M | +36.6% |
| Accounts Receivable | $815.2M | -46.5% |
| Inventory | $1.08B | -32.0% |
| Current Assets | $2.86B | -23.2% |
| Total Assets | $9.37B | -19.8% |
| Current Liabilities | $1.41B | -33.1% |
| Long-term Debt | $9.25B | -2.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $289.9M | +52.6% |
| Capital Expenditures | $53.3M | -47.4% |
| Investing Cash Flow | $38.3M | +146.7% |
| Financing Cash Flow | -$181.7M | -179.5% |
| Free Cash Flow | $236.6M | +166.7% |
| +1118.3% |
| Net Income | -$1.45B | -12.7% |
| EPS (Basic) | -$7.17 | -10.5% |
| EPS (Diluted) | -$7.17 | -10.5% |
| Total Liabilities |
| $11.18B |
| -7.9% |
| Stockholders' Equity | -$2.97B | -92.0% |